BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31992504)

  • 1. Outcomes in Adult Acute Promyelocytic Leukemia: A Decade Experience.
    Yedla RP; Bala SC; Pydi VR; Kuruva SP; Chennamaneni R; Konatam ML; Paul TR; Gundeti S
    Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):e158-e164. PubMed ID: 31992504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience.
    Pagnano KB; Traina F; Takahashi T; Oliveira GB; Rossini MS; Lorand-Metze I; Vigorito AC; Miranda EC; De Souza CA
    Sao Paulo Med J; 2000 Nov; 118(6):173-8. PubMed ID: 11120548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications during Induction Chemotherapy in Acute Promyelocytic Leukemia: An Institutional Experience.
    Yedla RP; Bala SC; Pydi VR; Chennamaneni R; Kuruva SP; Konatam ML; Gundeti S
    South Asian J Cancer; 2023 Jul; 12(3):274-279. PubMed ID: 38047056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.
    Head D; Kopecky KJ; Weick J; Files JC; Ryan D; Foucar K; Montiel M; Bickers J; Fishleder A; Miller M
    Blood; 1995 Sep; 86(5):1717-28. PubMed ID: 7655004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
    Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
    Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia - A retrospective clinical study.
    Ge F; Zhang Y; Cao F; Li J; Hou J; Wang P; Li H; Xu M; Liu S; Li L; Li X; Wang S; Lv C; Su Y; Zhou J
    Hematology; 2016 Jun; 21(5):287-94. PubMed ID: 26871996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy.
    Ciftciler R; Haznedaroglu IC; Ozcebe O; Aksu S; Sayınalp N; Goker H; Demiroglu H; Buyukasık Y
    Immunopharmacol Immunotoxicol; 2020 Feb; 42(1):17-21. PubMed ID: 31744339
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
    Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
    Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
    Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
    Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.
    Chen X; Fan S; Zhao Y; Zhou J
    Clin Transl Oncol; 2021 Oct; 23(10):2171-2180. PubMed ID: 33942222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
    Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
    Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience.
    Akcay OF; Yeter HH; Buyukasik Y
    Rom J Intern Med; 2020 Sep; 58(3):138-145. PubMed ID: 32452194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG).
    Wanitpongpun C; Utchariyaprasit E; Owattanapanich W; Tantiworawit A; Rattarittamrong E; Niparuck P; Puavilai T; Julamanee J; Saelue P; Chanswangphuwana C; Polprasert C; Nakhakes C; Limvorapitak W; Kanitsap N; Prayongratana K; Sriswasdi C
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e635-e643. PubMed ID: 33926829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early death in acute promyelocytic leukemia: Evidence from a rural cancer center.
    Golamari KR; Mikkilineni A; Chappidi S
    Indian J Cancer; 2020; 57(4):451-456. PubMed ID: 33078753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem.
    Latagliata R; Petti MC; Fenu S; Mancini M; Spiriti MA; Breccia M; Brunetti GA; Avvisati G; Lo Coco F; Mandelli F
    Blood; 2002 Feb; 99(3):822-4. PubMed ID: 11806982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.
    Kanamaru A; Takemoto Y; Tanimoto M; Murakami H; Asou N; Kobayashi T; Kuriyama K; Ohmoto E; Sakamaki H; Tsubaki K
    Blood; 1995 Mar; 85(5):1202-6. PubMed ID: 7858250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.